U.S., Feb. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07385755) titled 'Desvenlafaxine for Preventive Treatment of Frequent Migraines' on Jan. 13.
Brief Summary: To evaluate whether Desvenlafaxine can reduce the frequency and severity of migraine attacks in patients.
Study Start Date: Jan. 01
Study Type: INTERVENTIONAL
Condition:
Migraine
Intervention:
DRUG: Desvenlafaxine
Desvenlafaxine
DRUG: Placebo
placebo
Recruitment Status: ACTIVE_NOT_RECRUITING
Sponsor: Tongji Hospital
Information provided by (Responsible Party): Wensheng Qu, Tongji Hospital
Published by HT Digital Content Services with permission from Health Daily Digest....